muscle wasting program (Immusoft)

N/A

Report date: 2025/03/20 15:52:41

Base Information

Drug Namemuscle wasting program (Immusoft)
Drug Alias NameFST gene therapy (Immusoft)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionFollistatin agonists
TargetsFollistatin
Therapy Area/IndicationsMuscular Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmusoft Corp
China Registration ClassN/A

Develop Information

Active CompaniesImmusoft Corp
Inactive CompaniesN/A
Active IndicationsMuscular Atrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A